This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

List of drugs at risk of Brexit shortage has shrunk sharply, says EU agency

( September 24, 2018, 17:14 GMT | Official Statement) -- MLex Summary: The number of centrally-authorized medicines at risk of Brexit-related supply disruptions inside the EU has fallen from 108 to 39, according to analysis by the European Medicines Agency. The agency is pushing drug makers to relocate their regulatory processes or manufacturing sites to maintain market access after the UK's departure.The statement follows....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections